Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
COVID-19 - Phocaeicola massiliensis |
📓
Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection. Life sciences (Life Sci ) Vol: Issue Pages: 122136 Pub: 2023 Sep 30 Epub: 2023 Sep 30 Authors Krasaewes K , Chaiwarith R , Chattipakorn N , Chattipakorn SC , Publication |
COVID-19 - Phocaeicola massiliensis |
📓
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal transduction and targeted therapy (Signal Transduct Target Ther ) Vol: 7 Issue 1 Pages: 143 Pub: 2022 Apr 29 Epub: 2022 Apr 29 Authors Wang B , Zhang L , Wang Y , Dai T , Qin Z , Zhou F , Zhang L , Publication |
COVID-19 - Phocaeicola massiliensis |
📓
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology (Gastroenterology ) Vol: 159 Issue 3 Pages: 944-955.e8 Pub: 2020 Sep Epub: 2020 May 20 Authors Zuo T , Zhang F , Lui GCY , Yeoh YK , Li AYL , Zhan H , Wan Y , Chung ACK , Cheung CP , Chen N , Lai CKC , Chen Z , Tso EYK , Fung KSC , Chan V , Ling L , Joynt G , Hui DSC , Chan FKL , Chan PKS , Ng SC , Publication |
COVID-19 - Phocaeicola massiliensis |
📓
Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora. Chemico-biological interactions (Chem Biol Interact ) Vol: 358 Issue Pages: 109898 Pub: 2022 May 1 Epub: 2022 Mar 21 Authors Alharbi KS , Singh Y , Hassan Almalki W , Rawat S , Afzal O , Alfawaz Altamimi AS , Kazmi I , Al-Abbasi FA , Alzarea SI , Singh SK , Bhatt S , Chellappan DK , Dua K , Gupta G , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.